Results
3
Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.
3 companies
Pharma Mar
Market Cap: €1.6b
A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally.
PHM
€91.20
7D
7.6%
1Y
101.5%
Grenergy Renovables
Market Cap: €1.9b
Operates as a green energy producer.
GRE
€68.00
7D
-2.3%
1Y
96.5%
Oryzon Genomics
Market Cap: €221.2m
A clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS disorders.
ORY
€2.81
7D
2.9%
1Y
49.7%